Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anastrozole (arimidex) (1 trial)
avb-s6-500 (1 trial)
bevacizumab (avastin) (4 trials)
carboplatin (paraplatin) (2 trials)
cisplatin (platinol) (2 trials)
defactinib (2 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (3 trials)
durvalumab (imfinzi) (1 trial)
gemcitabine (gemzar) (2 trials)
gl-onc1 (1 trial)
Lerociclib (1 trial)
letrozole (femara) (3 trials)
Modified RNA Vaccine Against Influenza (1 trial)
navtemadlin (1 trial)
Ofranergene obadenovec (1 trial)
olaparib (lynparza) (1 trial)
paclitaxel (taxol) (7 trials)
ro5126766 (1 trial)
selinexor (Xpovio) (1 trial)
skb264 (1 trial)
topotecan (hycamtin) (1 trial)
Afamitresgene autoleucel (1 trial)
alpelisib (Piqray) (1 trial)
atezolizumab (Tecentriq) (2 trials)
cobimetinib (cotellic) (1 trial)
epacadostat (1 trial)
fulvestrant (faslodex) (1 trial)
ipatasertib (1 trial)
onc-392 (1 trial)
pembrolizumab (keytruda) (1 trial)
pemigatinib (Pemazyre) (1 trial)
prexasertib (1 trial)
retifanlimab (Zynyz) (1 trial)
trastuzumab emtansine (kadcyla) (1 trial)
vb10.16 (1 trial)
vs-6766 (1 trial)
nxp800 (1 trial)
Carcinoma, Ovarian Epithelial (Phase 3)
Endometrial Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 3)
Trials (21 total)
Trial APIs (38 total)